A quantitative model of thermal stabilization and destabilization of proteins by ligands

Biophysical Journal

Volumn 95, Issue 7, 2008, Pages 3222-3231

  Cimmperman, Piotras ^a   Baranauskiene, Lina ^a   Jachimovičiute, Simona ^b   Jachno, Jelena ^a   Torresan, Jolanta ^a   Michailoviene, Vilma ^a   Matuliene, Jurgita ^a   Sereikaite, Jolanta ^b   Bumelis, Vladas ^b   Matulis, Daumantas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b VILNIUS GEDIMINAS TECHNICAL UNIVERSITY   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; CELL CYCLE PROTEIN; GROWTH HORMONE; LIGAND; ONCOPROTEIN; POLO LIKE KINASE 1; POLO-LIKE KINASE 1; PROTEIN; PROTEIN SERINE THREONINE KINASE; ZINC;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; HEAT; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN TERTIARY STRUCTURE; QUANTUM THEORY; SWINE; TEMPERATURE; THERMODYNAMICS; TRANSITION TEMPERATURE;

ANIMALS; CARBONIC ANHYDRASES; CELL CYCLE PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE; HEAT; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; QUANTUM THEORY; SWINE; TEMPERATURE; THERMODYNAMICS; TRANSITION TEMPERATURE; ZINC;

EID: 56049092342     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.108.134973     Document Type: Article

References (34)

1. Lo, M. C., A. Aulabaugh, G. Jin, R. Cowling, J. Bard, M. Malamas, and G. Ellestad. 2004. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal. Biochem. 332:153-159.
2. Pantoliano, M. W., E. C. Petrella, J. D. Kwasnoski, V. S. Lobanov, J. Myslik, E. Graf, T. Carver, E. Asel, B. A. Springer, P. Lane, and F. R. Salemme. 2001. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J. Biomol. Screen. 6:429-440.
3. Todd, M. J., and F. R. Salemme. 2003. Direct binding assays for pharma screening. Genet. Eng. News. 23.
4. Cummings, M. D., M. A. Farnum, and M. I. Nelen. 2006. Universal screening methods and applications of ThermoFluor. J. Biomol. Screen. 11:854-863.
5. Koblish, H. K., S. Zhao, C. F. Franks, R. R. Donatelli, R. M. Tominovich, L. V. LaFrance, K. A. Leonard, J. M. Gushue, D. J. Parks, R. R. Calvo, K. L. Milkiewicz, J. J. Marugi̧n, P. Raboisson, M. D. Cummings, B. L. Grasberger, D. L. Johnson, T. Lu, C. J. Molloy, and A. C. Maroney. 2006. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo. Mol. Cancer Ther. 5:160-169.
6. Parks, D. J., L. V. Lafrance, R. R. Calvo, K. L. Milkiewicz, V. Gupta, J. Lattanze, K. Ramachandren, T. E. Carver, E. C. Petrella, M. D. Cummings, D. Maguire, B. L. Grasberger, and T. Lu. 2005. 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR. Bioorg. Med. Chem. Lett. 15:765-770.
7. Grasberger, B. L., T. Lu, C. Schubert, D. J. Parks, T. E. Carver, H. K. Koblish, M. D. Cummings, L. V. LaFrance, K. L. Milkiewicz, R. R. Calvo, D. Maguire, J. Lattanze, C. F. Franks, S. Zhao, K. Ramachandren, G. R. Bylebyl, M. Zhang, C. L. Manthey, E. C. Petrella, M. W. Pantoliano, I. C. Deckman, J. C. Spurlino, A. C. Maroney, B. E. Tomczuk, C. J. Molloy, and R. F. Bone. 2005. Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. J. Med. Chem. 48:909-912.
8. Klinger, A. L., D. F. McComsey, V. Smith-Swintosky, R. P. Shank, and B. E. Maryanoff. 2006. Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements. J. Med. Chem. 49:3496-3500.
9. Matulis, D., J. K. Kranz, F. R. Salemme, and M. J. Todd. 2005. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry. 44:5258-5266.
10. Mezzasalma, T. M., J. K. Kranz, W. Chan, G. T. Struble, C. Schalk-Hihi, I. C. Deckman, B. A. Springer, and M. J. Todd. 2007. Enhancing recombinant protein quality and yield by protein stability profiling. J. Biomol. Screen. 12:418-428.
11. Abad, M. C., H. Askari, J. O'Neill, A. L. Klinger, C. Milligan, F. Lewandowski, B. Springer, J. Spurlino, and D. Rentzeperis. 2007. Structural determination of estrogen-related receptor gamma in the presence of phenol derivative compounds. J. Steroid Biochem. Mol. Biol. 1-2:44-54.
12. Kervinen, J., H. Ma, S. Bayoumy, C. Schubert, C. Milligan, F. Lewandowski, K. Moriarty, R. L. Desjarlais, K. Ramachandren, H. Wang, C. A. Harris, B. Grasberger, M. Todd, B. A. Springer, and I. Deckman. 2006. Effect of construct design on MAPKAP kinase-2 activity, thermodynamic stability and ligand-binding affinity. Arch. Biochem. Biophys. 449:47-56.
13. Ericsson, U. B., B. M. Hallberg, G. T. Detitta, N. Dekker, and P. Nordlund. 2006. ThermoFluor-based high-throughput stability optimization of proteins for structural studies. Anal. Biochem. 357:289-298.
14. Carver, T. E., B. Bordeau, M. D. Cummings, E. C. Petrella, M. J. Pucci, L. E. Zawadzke, B. A. Dougherty, J. A. Tredup, J. W. Bryson, J. Yanchunas, M. L. Doyle, M. R. Witmer, M. I. Nelen, R. L. DesJarlais, E. P. Jaeger, H. Devine, E. D. Asel, B. A. Springer, R. Bone, F. R. Salemme, and M. J. Todd. 2005. Decrypting the biochemical function of an essential gene from Streptococcus pneumoniae using ThermoFluor technology. J. Biol. Chem. 280:11704-11712.
15. Brandts, J. F., and L. N. Lin. 1990. Study of strong to ultratight protein interactions using differential scanning calorimetry. Biochemistry. 29:6927-6940.
16. Zvirblis, G. S., V. G. Gorbulev, P. M. Rubtsov, B. K. Chornov, J. B. Golova, B. E. Pozmogova, K. G. Skryabin, and A. A. Bayev. 1988. Genetic engineering of peptide hormones. III. The cloning of the porcine growth hormone cDNA and the construction of the gene suitable for the hormone expression in bacteria. Mol. Biol. (Mosk.). 22:145-150.
17. Baranauskaite, L., J. Sereikaite, G. Gedminiene, Z. Bumeliene, and V. Bumelis. 2005. Refolding of porcine growth hormone from inclusion bodies of Escherichia coli. Biocatal. Biotransform. 23:185-189.
18. Sereikaite, J., and V. Bumelis. 2006. Separation of recombinant porcine growth hormone monomer from dimer and other oligomers in the production process from E. coli inclusion bodies. Biologija (Vilnius). 3:67-69.
19. Beattie, J., V. Borromeo, S. Bramani, C. Secchi, W. R. Baumbach, and J. Mockridge. 1999. Effects of complexation with in vivo enhancing monoclonal antibodies on activity of growth hormone in two responsive cell culture systems. J. Mol. Endocrinol. 23:307-313.
20. Borromeo, V., J. Sereikaite, V. A. Bumelis, C. Secchi, A. Scire, A. Ausili, S. D'Auria, and F. Tanfani. 2008. Mink growth hormone structural-functional relationships: effects of renaturing and storage conditions. Protein. J. 27:170-180.
21. Pocker, Y., and J. T. Stone. 1967. The catalytic versatility of erythrocyte carbonic anhydrase. 3. Kinetic studies of the enzyme-catalyzed hydrolysis of p-nitrophenyl acetate. Biochemistry. 6:668-678.
22. Matulis, D., and M. J. Todd. 2004. Thermodynamics - structure correlations of sulfonamide inhibitor binding to carbonic anhydrase. In Biocalorimetry 2. J. E. Ladbury and M. L. Doyle, editors. Wiley. 107-132.
23. Dudutiene, V., L. Baranauskiene, and D. Matulis. 2007. Benzimidazo [1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase. Bioorg. Med. Chem. Lett. 17:3335-3338.
24. Elia, A. E., P. Rellos, L. F. Haire, J. W. Chao, F. J. Ivins, K. Hoepker, D. Mohammad, L. C. Cantley, S. J. Smerdon, and M. B. Yaffe. 2003. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell. 115:83-95.
25. Brent, R. P. 1973. Algorithms for Minimization without Derivatives. Prentice-Hall, Englewood Cliffs, New Jersey.
26. Cooper, A., M. A. Nutley, and A. Wadood. 2001. Differential scanning calorimetry. In Protein-Ligand Interactions: Hydrodynamics and Calorimetry. A Practical Approach. S. E. Harding and B. Z. Chowdhry, editors. Oxford University Press, New York. 287-318.
27. Garcia-Alvarez, B., G. de Carcer, S. Ibanez, E. Bragado-Nilsson, and G. Montoya. 2007. Molecular and structural basis of Polo-like kinase 1 substrate recognition: implications in centrosomal localization. Proc. Natl. Acad. Sci. USA. 104:3107-3112.
28. Dattani, M. T., P. C. Hindmarsh, C. G. Brook, I. C. Robinson, T. Weir, and N. J. Marshall. 1993. Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system. Endocrinology. 133:2803-2808.
29. Duda, K. M., and C. L. Brooks. 2003. Differential effects of zinc on functionally distinct human growth hormone mutations. Protein Eng. 16:531-534.
30. Cunningham, B. C., S. Bass, G. Fuh, and J. A. Wells. 1990. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science. 250:1709-1712.
31. Cunningham, B. C., M. G. Mulkerrin, and J. A. Wells. 1991. Dimerization of human growth hormone by zinc. Science. 253:545-548.
32. Parkinson, E. J., M. B. Morris, and S. Bastiras. 2000. Acid denaturation of recombinant porcine growth hormone: formation and self-association of folding intermediates. Biochemistry. 39:12345-12354.
33. Schulga, A. A., A. A. Makarov, I. V. Levichkin, Y. V. Belousova, V. M. Lobachov, I. I. Protasevich, C. N. Pace, and M. P. Kirpichnikov. 2002. Increased stability of human growth hormone with reduced lactogenic potency. FEBS Lett. 528:257-260.
34. Yang, T. H., J. L. Cleland, X. Lam, J. D. Meyer, L. S. Jones, T. W. Randolph, M. C. Manning, and J. F. Carpenter. 2000. Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor. J. Pharm. Sci. 89:1480-1485.